Clinical trial

An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).

NCT02321046

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-09-02

PhaseN/A

Study timeline

Study start (actual)2015-09-02Date precision: day

Registry last updated2020-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

MoscowRussia1 Saint PetersburgRussia1 NovosibirskRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02321046 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.